
James A. Himes Periodic Transaction Report
Filed Mar 5, 2023 · House Clerk · 1 transaction
U.S. Representative · D · CT-04 · All trades by James A. Himes
On March 5, 2023, Rep. James A. Himes (D-CT-04) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated Feb 22, 2023.
The one asset reported, Fidelity 2022 Private Equity Multi Strategy, is listed without a stock ticker. The filer coded it as "Hedge Funds & Private Equity Funds (non-EIF)" on the House form.
Reported amount ranges sum to $50K–$100K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 11 days.
1 transaction was reported under a spouse, dependent child, or joint account rather than the member directly.
Source document: House Clerk filing 20022515
Sample · the intelligence layer
James A. Himes · Bought · Feb 22 · $50K–$100K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow James A. Himes
Get an email the moment James A. Himes files the next one. Free, no card, no spam.
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Feb 22, 2023 | — | Fidelity 2022 Private Equity Multi Strategy Hedge Funds & Private Equity Funds (non-EIF) | buy | Joint | $50K–$100K | 11d |
The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.
Other recent filings by James A. Himes
- PTR filed Oct 20, 20261 trade
- PTR filed Jul 20, 20263 trades · BAC, HD, XOM
← All congressional filings, newest firstFiled Mar 5, 2023March 2023 archive
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →